Provention Bio, Inc.
PRVBDelisted Apr 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001695357
Provention Bio, Inc. was delisted on Apr 27, 2023; its insiders filed their last Form 4 on Apr 28, 2023; 183 institutions reported holding it in 13F filings for Q1 2023, worth $1.47B in total; Fairfax Financial was the only superinvestor holding it.
Q4 2022 vs. Q3 2022
How the institutions holding Provention Bio, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 112 | 133 | +21 |
| Shares | 41.6M | 45.2M | +3.59M (+8.6%) |
| Value | $187.1M | $477.4M | +$290.3M (+155.2%) |
New holders (38)
Institutions that held Provention Bio, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
Sold out (17)
Institutions that held Provention Bio, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| DG Capital Management, LLC | 499,271 | $2.25M |
| Perceptive Advisors LLC | 110,728 | $498.0K |
| XTX Topco Ltd | 86,763 | $390.0K |
| Marshall Wace, LLP | 80,685 | $362.0K |
| Graham Capital Management, L.P. | 80,163 | $360.0K |
| Gsa Capital Partners LLP | 61,337 | $276.0K |
| PDT Partners, LLC | 51,594 | $232.0K |
| Renaissance Technologies LLC | 31,321 | $141.0K |
| STRS Ohio | 28,900 | $130.0K |
| Ensign Peak Advisors, Inc | 24,840 | $112.0K |
| Aquatic Capital Management LLC | 19,200 | $86.0K |
| Susquehanna Fundamental Investments, LLC | 18,591 | $84.0K |
| Forefront Analytics, LLC | 14,997 | $68.0K |
| J.W. Cole Advisors, Inc. | 14,750 | $66.0K |
| AQR Capital Management LLC | 13,864 | $62.0K |
| Wolverine Trading, LLC | 13,114 | $58.0K |
| Cantor Fitzgerald, L. P. | 10,000 | $45.0K |